Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Astilin 10mg Tablets - PA23163/001/001
- Brufen 400mg Film-Coated Tablets - PA2010/002/001
- CellCept 500mg Powder for Concentrate for Solution for Infusion - EU/1/96/005/005
- Co-Amoxiclav Teva 500mg/100mg Powder for Solution for Injection/Infusion - PA0749/011/001
- Distaclor LA 375mg Prolonged Release Tablets, - PA1226/001/004
- Innohep 10,000 IU in 0.5 ml, Solution for Injection - PA0046/060/010
- Monotrim 100mg Tablets - PA22643/002/002
- Monotrim 200mg Tablets - PA22643/002/003
- Pregabalin Krka 75mg Hard Capsules - PA1347/050/003
- Rifadin 300mg Capsules - PA540/066/002
- Sandimmun 100mg/ml Concentrate for Oral Solution - PA0896/027/001
- Tecentriq 1200mg Concentrate for Solution for infusion - EU/1/17/1220/001
- Trileptal 150mg Film-Coated Tablets - PA0896/033/001
- Valaciclovir 500mg Film-Coated Tablets - PA2315/102/001
- Xarelto 1mg/ml Granules for Oral Suspension (100ml bottle) - EU/1/08/472/050
The following shortages have been resolved and supply has resumed to the Irish market:
- Actilyse 50mg Powder and Solvent for Solution for Injection and Infusion - PA0775/011/003
- Brevibloc Premixed 10mg/ml Solution for Infusion - PA2299/021/002
- Calvepen 666mg Tablets - PA0126/137/002
- Emtricitabine/Tenofovir disoproxil Mylan 200mg/245mg Film Coated Tablets - EU/1/16/1133/001-009
- Fucidin H 20mg/g + 10mg/g Cream - PA0046/005/005
- Gentamicin 40mgml Solution for Injection or Infusion - PA0281/242/002
- Lipitor 40mg Film Coated Tablets - PA23055/017/004
- Midazolam 5mg/ml Solution for Injection or Infusion - PA2315/063/006
- Ozempic 0.25mg solution for Injection in Pre-Filled Pen - EU/1/17/1251/002
- Relestat, 0.5mg/ml, Eye Drops - PA1824/018/001
- Tobi 300mg/5ml Nebuliser Solution - PA2010/063/001
- Tuberculin PPD RT23 AJV 2 T.U./0.1 mL, Solution for Injection - PA2160/004/001
- Zofran 4mg/5ml Syrup - PA0896/036/003
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.